Gallagher et al., paper summarizing the 2 landmark Trials PONTIAC 1 and STOP-HF stating the use of NT-pro BNP is an effective tool in refining risk prediction for heart failure and cardiovascular disease and adding predictive power to conventional risk factors (104). This evidence concerns the gene NPPB and hydrops fetalis.